Chronic obstructive pulmonary disease, commonly called COPD, is one of the leading causes of illness and death worldwide. The disease slowly damages the lungs, making it increasingly difficult to ...

For the first time, patients have received a new injection for chronic obstructive pulmonary disease (COPD), thanks to ...

For many people living with COPD, every breath can become a struggle. The disease gradually damages the lungs, limiting airflow and making everyday activities increasingly difficult. In the United ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a ...

A new treatment is offering hope to people living with severe asthma, especially those who rely on daily steroid tablets to keep their symptoms under control. A large international study has found ...

Exdensur is the first and only long-acting biologic with twice-yearly dosing approved in Canada for severe asthma ...

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...

Asthma and chronic obstructive pulmonary disease (COPD) incur significant comorbidity and healthcare burden. However, their future economic burden remain unclear. Patients with asthma (all ages) or ...